ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS
· Real-Time Price · USD
3.92
0.72 (22.50%)
At close: Aug 14, 2025, 3:59 PM
ReShape Lifesciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.46M | -7.13M | -7.07M | -9.02M | -10.92M | -11.39M | -26.3M | -34.95M | -40.9M | -46.46M | -65.3M | -70.82M | -65.27M | -61.93M | -35.01M | -22.49M | -22.19M |
Depreciation & Amortization | 20K | 22K | 24K | 69K | 112K | 154K | 662K | 1.16M | 1.65M | 2.15M | 2.19M | 2.2M | 2.1M | 1.97M | 1.83M | 1.7M | 1.66M |
Stock-Based Compensation | 127K | 184K | 279K | 463K | 616K | 766K | 786K | 928K | 1.48M | 1.98M | 4.14M | 14.5M | 13.37M | 12.75M | 10.75M | 286K | 997K |
Other Working Capital | -1.53M | -1.48M | -1.44M | 461K | 136K | -337K | -1.02M | -1.1M | -885K | -448K | 155K | -3.82M | -2.78M | -2.96M | -2.6M | 1.61M | 779K |
Other Non-Cash Items | -1.53M | 1.4M | 884K | -358K | -599K | -2.39M | 10.15M | 9.45M | 9.78M | 12.48M | 100K | 126K | 190K | 627K | 6.33M | 7M | 7.71M |
Deferred Income Tax | 1K | 6K | 27K | 30K | 34K | 32K | 137K | -233K | -238K | -424K | 28.3M | 31.63M | 31.77M | 33.95M | 5.01M | 4.53M | 4.62M |
Change in Working Capital | 375K | 673K | -761K | -267K | -3.63M | -4.13M | -2.77M | -3.65M | 861K | 551K | 261K | -3M | -2.98M | -2.74M | -2.62M | 2.09M | -55K |
Operating Cash Flow | -4.47M | -4.43M | -6.2M | -8.67M | -13.97M | -16.96M | -17.33M | -19.83M | -19.59M | -21.9M | -22.5M | -25.03M | -20.79M | -15.38M | -13.71M | -6.89M | -7.27M |
Capital Expenditures | n/a | n/a | n/a | n/a | -36K | -43K | -122K | -155K | -131K | -131K | -119K | -175K | -240K | -352K | -445K | -504K | -509K |
Cash Acquisitions | n/a | n/a | -33K | -33K | n/a | n/a | 33K | 33K | 30K | 39K | -2.96M | -8.17M | -2.99M | -3M | -2M | 3.21M | -2M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 3.24M | 3.24M | 3.24M | 13.44M | 10.2M | 10.2M | 10.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 33K | -10.17M | -10.21M | -10.21M | -10.21M | n/a | -5.17M | 39K | 5.22M | 5.21M | 8.41M | 3.21M | -2M |
Investing Cash Flow | n/a | n/a | 3.2M | 3.2M | 3.2M | 3.19M | -89K | -122K | -101K | -92K | -3.08M | -3.14M | 1.98M | 1.85M | 2.76M | 2.7M | -2.51M |
Debt Repayment | -811K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | 6M | 7.5M | 8.96M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.43M | 677K | 5.49M | 5.15M | 7.37M | 7.37M | 2.55M | 2.89M | 3.13M | 3.13M | 2.49M | -745K | 32.1M | 32.1M | 32.17M | 35.4M | 645K |
Financial Cash Flow | 4.62M | 677K | 5.49M | 5.15M | 7.37M | 17.57M | 12.75M | 13.09M | 13.33M | 3.13M | 2.49M | -544K | 32.3M | 33.3M | 38.37M | 42.9M | 9.6M |
Net Cash Flow | 136K | -3.77M | -706K | -3.51M | -6.6M | 604K | -4.7M | -6.88M | -6.38M | -18.86M | -23.05M | -28.67M | 13.51M | 19.81M | 27.39M | 38.64M | -221K |
Free Cash Flow | -4.47M | -4.43M | -6.2M | -8.67M | -14.01M | -17M | -17.45M | -19.98M | -19.72M | -22.03M | -22.62M | -25.2M | -21.03M | -15.73M | -14.16M | -7.39M | -7.78M |